{
    "clinical_study": {
        "@rank": "30325", 
        "arm_group": {
            "arm_group_label": "glyceryl trierucate /glyceryl trioleate mixture", 
            "arm_group_type": "Other", 
            "description": "glyceryl trierucate and glyceryl trioleate mixture, 2-4 tablespoons once daily"
        }, 
        "brief_summary": {
            "textblock": "OBJECTIVES: I.  Evaluate the clinical efficacy of combination glyceryl trierucate and\n      glyceryl trioleate (Lorenzo's Oil) therapy in boys with X-linked adrenoleukodystrophy.\n\n      II.  Compare the frequency and severity of neurological disability of study patients with\n      untreated historical controls."
        }, 
        "brief_title": "Effect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy", 
        "condition": "Adrenoleukodystrophy", 
        "condition_browse": {
            "mesh_term": "Adrenoleukodystrophy"
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE: This is an open label study. Patients must follow dietary instructions as\n      provided by the investigator. Patients receive 2-4 tablespoons of a mixture of glyceryl\n      trierucate and glyceryl trioleate oil once daily.  Patients complete a neuropsychological\n      scoring scale questionnaire to measure neurological disability.  Patients undergo physical\n      examinations including magnetic resonance imaging and magnetic resonance spectroscopy of the\n      head.\n\n      Patients are followed monthly for 6 months, then every 3 months until death."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  Biochemically proven asymptomatic X-linked adrenoleukodystrophy\n\n          -  Platelet count in normal range"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "6 Years", 
            "minimum_age": "18 Months"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 18, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004418", 
            "org_study_id": "199/13312", 
            "secondary_id": [
                "Nutricia-Loma Linda", 
                "KKI-FDR000685"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "glyceryl trierucate /glyceryl trioleate mixture", 
                "intervention_name": "glyceryl trierucate", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "glyceryl trierucate /glyceryl trioleate mixture", 
                "description": "Patients receive 2-4 tablespoons of a mixture of glyceryl trierucate and glyceryl trioleate oil once daily.", 
                "intervention_name": "glyceryl trioleate", 
                "intervention_type": "Drug", 
                "other_name": "Lorenzo's Oil"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "adrenoleukodystrophy", 
            "inborn errors of metabolism", 
            "rare disease", 
            "sphingolipidoses"
        ], 
        "lastchanged_date": "February 5, 2013", 
        "location": [
            {
                "contact": {
                    "last_name": "Kim Hollandsworth", 
                    "phone": "800-873-3377", 
                    "phone_ext": "2772"
                }, 
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21287-6681"
                    }, 
                    "name": "Johns Hopkins Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21205"
                    }, 
                    "name": "Kennedy Krieger Institute"
                }, 
                "status": "Active, not recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Study of Glyceryl Trierucate and Glyceryl Trioleate (Lorenzo's Oil) Therapy in Male Children With Adrenoleukodystrophy", 
        "other_outcome": {
            "measure": "very long chain fatty acids (VLCFA)", 
            "safety_issue": "No", 
            "time_frame": "every month during first year, then every 1-3 months"
        }, 
        "overall_official": {
            "affiliation": "Hugo W. Moser Research Institute at Kennedy Krieger, Inc.", 
            "last_name": "Gerald V Raymond, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "neurological disability", 
            "safety_issue": "No", 
            "time_frame": "6 months post intervention, then every 3 months until age 13 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004418"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hugo W. Moser Research Institute at Kennedy Krieger, Inc.", 
            "investigator_full_name": "Gerald Raymond", 
            "investigator_title": "Associate Professor of Neurology, Johns Hopkins University School of Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "magnetic resonance imaging of the head", 
            "safety_issue": "No", 
            "time_frame": "yearly"
        }, 
        "source": "Hugo W. Moser Research Institute at Kennedy Krieger, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hugo W. Moser Research Institute at Kennedy Krieger, Inc.", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 1998", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }, 
    "geocoordinates": {
        "Johns Hopkins Hospital": "39.29 -76.612", 
        "Kennedy Krieger Institute": "39.29 -76.612"
    }
}